IGF1 and cancer: We also identify transcriptionally discrete iCAF phenotypes including a low activation/transition phenotype (IGF1+), likely the predominant iCAF in the current literature, as well as a more highly inflammatory IL11 + CAF subtype found within cancers of the GI tract.